<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03348709</url>
  </required_header>
  <id_info>
    <org_study_id>1-10-72-12-17</org_study_id>
    <nct_id>NCT03348709</nct_id>
  </id_info>
  <brief_title>Osmolality of Oral Supplements and Ileostomy Output</brief_title>
  <official_title>Does Osmolality of Oral Supplements Affect Stoma Output and Natriuresis in Patients With an Ileostomy?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Copenhagen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Aarhus</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This double-blinded, active comparator, cross-over intervention study tested the impact of
      two different oral supplements on ileostomy output volume and urinary sodium excretion and
      intestinal aquaporin expression in eight compensated patients with an ileostomy and not on
      home parenteral Nutrition or fluid support.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with an ileostomy may experience fluid and electrolyte imbalances sedondary to an
      unregulated intestinal loss of water and electrolytes. The osmolality of oral supplements may
      affect these losses. In a double-blinded, active comparator, cross-over intervention study,
      the investigators test the effects of substituting 800 ml of the usual fluid intake with an
      intake of either an isoosmolar (300 mOsm/kg) or hyperosmolar (700 mOsm/kg) supplement during
      48 hours, following baseline data collection before both intervention periods. Outcome
      measures were stoma output volume, 24-hour urine and urinary sodium excretion, and intestinal
      aquaporin 3 and 8 expressions.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2017</start_date>
  <completion_date type="Anticipated">June 30, 2018</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Double-blinded, active comparator, cross-over intervention study</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>Randomisation by Third party; Unblinded study nurse to mix and deliver study product; masking of product to ensure comparable palatability and appearance; blinding to analyses</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Stoma output</measure>
    <time_frame>24 hours</time_frame>
    <description>24 hour stoma output weight</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>24-hour urine production</measure>
    <time_frame>24 hours</time_frame>
    <description>24 hour urine volume (ml)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>24-hour urinary sodium excretion</measure>
    <time_frame>24 hours</time_frame>
    <description>24-hour sodium (mmol)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">8</enrollment>
  <condition>Ileostomy - Stoma</condition>
  <condition>Short Bowel Syndrome</condition>
  <condition>Sodium Depletion</condition>
  <condition>Nutritional Deficiency</condition>
  <arm_group>
    <arm_group_label>Isoosmolar</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Iso-osmolar oral supplement (276 mOsm/kg)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hyperosmolar</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Hyper-osmolar oral supplement (681 mOsm/kg)</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Isoosmolar</intervention_name>
    <description>48 hours, 800 ml per 24 hours</description>
    <arm_group_label>Isoosmolar</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Hyperosmolar</intervention_name>
    <description>48 hours, 800 ml per 24 hours</description>
    <arm_group_label>Hyperosmolar</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age 18 years or more

          -  ilestomy established 6 weeks or more prior to inclusion

          -  able to drink at least 100 ml fluid per 24 hours

          -  i known inflammatory bowel disease, clinical remission judged by physician's global
             assessment (PGA)

          -  less than 5 kg self-reported weight change during the past 3 months

        Exclusion Criteria:

          -  self-reported intolerance to dairy products, including lactose

          -  known renal insufficiency, defined by an eGFR less than 30 ml/min

          -  known diabetes mellitus, defined by an HbA1C &gt; 48 mmol/mol (6.5%)

          -  current enteral tube feeding or parenteral fluid or Nutrition support more than twice
             weekly
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hendrik Vilstrup, Professor</last_name>
    <role>Study Chair</role>
    <affiliation>University of Aarhus</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hendrik Vilstrup, Professor</last_name>
    <phone>+4578463892</phone>
    <email>vilstrup@clin.au.dk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Aarhus University Hospital</name>
      <address>
        <city>Aarhus C</city>
        <zip>8000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian L Hvas, MD PhD</last_name>
      <email>chrishva@rm.dk</email>
    </contact>
    <contact_backup>
      <last_name>Jens F Dahlerup, MD DrMSc</last_name>
      <email>jensdahl@rm.dk</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 16, 2017</study_first_submitted>
  <study_first_submitted_qc>November 16, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 21, 2017</study_first_posted>
  <last_update_submitted>November 20, 2017</last_update_submitted>
  <last_update_submitted_qc>November 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 22, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Aarhus</investigator_affiliation>
    <investigator_full_name>Christian Hvas</investigator_full_name>
    <investigator_title>MD PhD, associate professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Short Bowel Syndrome</mesh_term>
    <mesh_term>Malnutrition</mesh_term>
    <mesh_term>Hyponatremia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Publication of anonymised data. Data backup in accessible data platform.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

